hydroxyproline has been researched along with obeticholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, E; Fiorucci, S; Mencarelli, A; Morelli, A; Orlandi, S; Pellicciari, R; Renga, B; Riccardi, L; Rizzo, G | 1 |
| Huang, X; Jiang, Z; Miao, Y; Tang, Q; Wang, J; Wu, Q; Xu, Y; Yu, Q; Yuan, Z; Zhang, H; Zhang, L; Zhang, Z | 1 |
2 other study(ies) available for hydroxyproline and obeticholic acid
| Article | Year |
|---|---|
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.
Topics: Animals; Chenodeoxycholic Acid; Cloning, Molecular; DNA-Binding Proteins; Hydroxyproline; Liver; Liver Cirrhosis, Experimental; Male; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Swine; Transcription Factors | 2004 |
Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis.
Topics: Alkaline Phosphatase; Animals; Chenodeoxycholic Acid; Cholestasis; Fibrosis; Hydroxyproline; Liver; Mice; Osteopontin | 2022 |